Advertisement
Advertisement

KLTO

KLTO logo

Klotho Neurosciences, Inc. Common Stock

0.53
USD
-0.01
-2.03%
Oct 31, 15:59 UTC -4
Closed
exchange

After-Market

0.53

0.00
+0.19%

Klotho Neurosciences, Inc. Common Stock Profile

About

Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK.

Info & Links

CEO

Joseph A. Sinkule

Headquarters

13576 WALNUT STREET, SUITE A
OMAHA, NE 68144, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.klothoneuro.com

Auditor

BCRG Group

Share holders

89

Employees

3

Klotho Neurosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

32.71M

Enterprise Value

24.28M

Enterprise Value/EBITDA(ttm)

-3.05

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.23

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-325.88%

Return on Invested Capital(ttm)

-765.22%

Return on Assets(ttm)

-242.15%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-7.95M

Net Income Available to Common(ttm)

-11.35M

Diluted EPS(ttm)

-0.45

Share Statistics

Beta (5Y Monthly)

10.05

52-Week Change

4.33%

S&P 500 52-Week Change

19.89%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

61.37M

Dividend Yield

0.00%

Float4

51.56M

% Held by Insiders

26.70%

% Held by Institutions

20.07%

Balance Sheet

Total Cash(mrq)

8.43M

Total Cash Per Share(mrq)

0.14

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

135.74%

Quick Ratio(mrq)

135.73%

Book Value Per Share(mrq)

0.20

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.10

Free Cash Flow(ytd)

-3.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement